The etiology of spongiform encephalopathies has been sharply contested for decades. At the heart of the issue is the question of disease origin: Are prion diseases representative of primary neurodegenerative genetic disorders, or are they bona fide infectious diseases? This article provides a brief outline of the progress made in the elucidation of prion disease mechanisms in the context of pathological support of the 'protein only' hypothesis. The answer to the above question appears to be that spongiform encephalopathies are uniquely both infectious and genetic neurodegenerative diseases.
Introduction
Prions have been implicated as the etiological agents responsible for a variety of neurodegenerative diseases in humans and animals. Scrapie in sheep, bovine spongiform encephalopathy or 'mad cow disease', transmissible mink encephalopathy, and chronic wasting in mule deer constitute the majority of known prion diseases in animals. Analogous human diseases include CreutzfeldtJakob disease, Gerstmann-Str~iussler syndrome, and kuru (Table 1) . These diseases can be infec-tious, familial, or sporadic in origin. Prions appear to be different from other infectious agents in that they are devoid of a detectable nucleic acid constituent [1] . The only recognized component of the infectious agent is a protein referred to as PrP so, which is encoded for by a normal cellular gene in the infected or diseased host [2] , making these diseases unique.
The purpose of this MiniReview is to provide a brief encounter with some of the issues at the heart of the prion enigma. Interest in these diseases has become particularly keen recently with reported iatrogenic cases of sporadic CJD as well as the BSE epidemic in Great Britain. The diseases are presented, and a discussion of disease pathology follows. Neurodegenerative pathology Table 1 Naturally occurring prion diseases in humans and animals Disease Human Kuru Creutzfeldt-Jakob disease (CJD) Gerstmann-Str~ussler syndrome (GSS) fatal familial insomnia (FFI) Animal scrapie sheep and goat transmissible mink encephalopathy (TME) mink bovine spongiform encephalopathy (BSE) cattle feline spongiform encephalopathy (FSE) cat chronic wasting disease mule deer has been attributed to PrP so, in addition to disease transmissibility. The major arguments providing key evidence for a central role of PrP sc in transmissibility and pathology follow, and new data from recent experiments using transgenic animal models are presented to close the discussion.
Spongiform encephalopathies (SE) and pathology
Fatal neurodegenerative diseases were first recognized at least 250 years ago in sheep. Scrapie, the form of the disease in sheep, is well documented, and was the first of this family of diseases shown to be transmissible. Preclinical infected animals appear normal, and the disease progresses through a series of characteristic symptoms over a period of two to six months before killing the animal. Other diseases may differ in incubation time, pathology, age of onset, duration, and host specificity, but the common underlying principle is the presence of PrP sc protein in the degenerating tissues. Interest in prion diseases has recently been stimulated with an epidemic of BSE in cattle in Great Britain, and the appearance of iatrogenic CJD in humans. The BSE epidemic has been attributed to a failure to inactivate the scrapie-causing agent in the rendering process; as a result, active agent was included in food supplements fed to cattle leading to an outbreak of BSE. It is expected that the cessation of these practices will lead to a reduction of BSE. A similar precedent was set by the elimination of cannibalistic funerary rituals in New Guinea which was responsible for the eradication of kuru. However, the clinical implications of supposed transmissibility of scrapie to cattle resulting in BSE has been met with concern.
The pathology of SE diseases is primarily limited to the central nervous system, although some endocrine organs also display pathological involvement in some diseases. Skeletal muscle has also been shown to undergo necrotizing degeneration in experimental models [3] . In scrapie, neurodegeneration progresses through a series of definitive stages; one of the stages is often associated with rubbing or scraping (hence the name scrapie). The pathological involvement of the central nervous system in this disease has been acknowledged for many years. However, the pathogenesis of scraping remains unknown.
Spongiform encephalopathies are characterized by two main pathological events. The most prominent feature is vacuolization in degenerating neurons possibly due to a disruption in membrane processing related to the presence of abnormal PrP. Vacuolated neurons assume a spongiform appearance in human disease and in experimental scrapie. The second main event is a glial response. PrP sc particles accumulate during progression of the condition, and their distribution demonstrates a wide range. It is the accumulation of these particles that is thought to cause serious disruption of normal brain functions.
Cell culture experiments have revealed the nature of prion protein fragment neurotoxicity. A fragment corresponding to peptide 106-126 of the amino acid sequence deduced from human PrP gene cDNA polymerized in vitro and was toxic to primary rat hippocampal cells. Cell death was determined to follow an apoptotic mechanism [4] . Scrapie-infected sheep brain samples assayed for DNA fragmentation showed greatly increased DNA migration using the comet assay as compared to scrapie-free control brain sampies. The DNA fragmentation was characteristic of apoptotic death [5] , lending in vivo support to the pathological observations of Forloni and coworkers [4] . That PrP sc accumulation is associ-ated with nerve degeneration and participates in a central role in the pathology of these diseases are supported by these findings.
PrP protein
The mechanisms of pathogenesis became much more clear with the discovery that prion diseases are transmissible, and that the agent responsible for their transmissibility is closely associated with a protein [6] . Purification of the protein and subsequent sequencing of the N-terminus led to cloning of the cDNA which showed that the protein was encoded by a chromosomal gene [7] [8] [9] . The synthesis and degradation of PrP has been shown to be rapid [2] . However, an isoform of the protein was isolated that accumulated in diseased animal tissues, escaping rapid degradation. The isoform was shown to be resistant to protease digestion [9] , in contrast to the normal cellular homologue PrP c, and is distinguished by the name PrP sc.
A primary role for PrP sc in the SE disease family has been shown by many lines of evidence. PrP 27-30, which is the resistant core of 27-30 kDa the peptide resulting from proteolytic cleavage of the first 67 amino acid residues from PrP sc, copurifies with scrapie infectivity [9] . Infectious agent purification protocols show that the most abundant protein in purified fractions is PrP 27-30 [6] . Similarly, PrP 27-30 concentration is directly proportional to infectious agent titer [9] . Antibodies to PrP 27-30 provide evidence for accumulation in all prion diseases [10] . Expectedly, PrP sc is absent in uninfected healthy animals [8] . These data suggest a central role for PrP sc in priori infectivity.
Further evidence has come from infectious agent neutralization studies. Antibody to PrP 27-30 precipitates the scrapie causing agent, and neutralizes infectivity in fractions [10] . Other methods for denaturing PrP sc also cause a decreased infectious titer [10] . Infectivity is resistant to a variety of chemical, UV, X-ray, and nuclease inactivation methods that normally inactivate viruses [6] . That these treatments do not alter infectivity, or PrP sc, argues against the presence of a nucleic acid component necessary for infectivity. These and other studies have provided evidence that PrP sc is the only constituent in the agent responsible for transmissibility. Intracellular PrP sc accumulation in cytoplasmic vesicles and secondary lysosomes is also responsible for the pathology of the diseases [11] .
PrP sc and PrP c differ with respect to not only their susceptibility to proteolytic degradation. PrP s~ is extremely hydrophobic, and as a result is insoluble (as is infectivity). Recent conformational studies also point to structural differences between the two isoforms. PrP s~ consists of secondary a-helical and /3-sheet structures at 30% and 43% respectively [12] . PrP c, in contrast, is virtually devoid of /3-sheet secondary structure (only 3%), and has a greater percentage of ahelical structure (42%) than PrP s~ [12] . It should be noted that the primary amino acid sequences of PrP c and PrP sc are identical [1, 8] .
PrP gene
The gene encoding PrP is located on human chromosome 20 and mouse chromosome 2 [10], and is expressed in both infected brains, uninfected brains, and other non-neuronal tissues [7, 8, 10] . Four regions in the gene are conserved [10] . The entire open reading frame is coded in a single exon [13] . This obviates the likelihood that PrP s~ and PrP c arise from an alternative splicing event.
The normal function of PrP remains unknown. However, clues from transgenic mice indicate that it is at least not necessary for normal development [14, 15] . Expression of PrP mRNA is the same in scrapie-infected animal tissues and in normal animal tissues [10] . Developmental regulation of PrP expression has been demonstrated, and expression is differentially regulated between neurons and glial cells [10] . The gene is not a constituent of the infectious unit [13] , arguing again for a central role of PrP sc as the primary infectious agent. It has been linked to a gene controlling incubation times [16] , and mutation of PrP demonstrates a change in susceptibility. This will be discussed later in further detail. Further- more, germline mutations in PrP are associated with familial human diseases ( Table 2 ).
Post-translational events
As the primary amino acid sequences of PrP sc and PrP c are identical [1, 8] , post-translational modifications in PrP c have been speculated to be responsible for PrP sc formation [2, 13, 17] . One of the supporting pieces of evidence for this hypothesis is that PrP is encoded for by a single exon. This precludes the formation of PrP sc by alternative splicing of PrP c mRNA transcripts [17] .
Several changes are made in the protein before it reaches its mature form bound to the outer membrane. A 22 amino acid residue signal peptide is cleaved from the amino terminus [13] and at the carboxy terminal end of the protein, 23 amino acid residues are removed [8] . A phosphatidylinositol glycolipid anchor is added to the carboxy end at Ser TM to anchor the protein to the membrane [18] . Additional modifications include a disulfide bond between Cys 179 and Cys 214, as well as glycosylations at Asn lsl and Asn 197 [10] . Experiments using the glycosylation inhibitor tunicamycin and mutated Asn glycosylation sites have demonstrated that glycosylation is not a necessary event for priori replication [10] . However, there is still no conclusive evidence that indicates that a post-translational modification (such as those previously mentioned) is responsible for the conversion of PrP c to PrP sc [1] .
Prion strains
The 'prion only' hypothesis disqualifies nucleic acid as a component of the infectious agent. A series of observations have been trumpeted to be a major difficulty with this view. The observations revolve primarily around the inability to reconcile the existence of prion strains in a protein only model. Prion strains are defined by incubation time and neuropathology exhibited as vacuolar lesion distribution, and PrP sc accumulation patterns [19] .
Incubation time is dependent at least in part by PrP expression levels, inoculum dosage, route of administration, and genetic origin of the inoculum and recipient. Genetic linkage to several genes has been established for incubation times. It is unclear whether the genes are identical, allelic or different altogether. Genes linked to long incubation times (Prn-i) are dominant [16] . PrP proteins differing at two amino acid residues have been shown to differ in incubation time. PrP sc in New Zealand white mice display a short incubation time, whereas a distinct isolate of PrP sc in I/Ln mice is characterized by a long incubation time [20] . The difference between the two isolates can be described as a difference in amino acids at codon 108 (Leu in NZW mice, and Phe in I/Ln mice) and codon 189 (Thr in NZW mice, and Val in I/Ln mice) [20] . These results define strain differences in the context of potential mutability or species variability, and require an explanation beyond the apparently counter-intuitive argument for PrP as the sole constituent of the scrapie agent.
Transmissibility of the scrapie agent has been proven since the 1930s. Serial transmission of PrP sc is allowable in animals homozygous for the same PrP genotype. It is possible to transmit the infectious agent from one species to another. However, there is an apparent 'species barrier' which is characterized by long incubation times. The incubation time decreases and stabilizes with subsequent passage. Prion proteins produced in the new host are defined by the PrP sequence of the host, and not the inoculum [21, 22] . Similarly, the neuropathology is defined by the genetic origin of the host.
Several postulations about the nature of the infectious agent have been presented to explain prion strain, and its relationship to the species barrier. Original assumptions that the disease is a manifestation of a virus-like organism with a strain-specific nucleic acid have been effectively dispelled by the disqualification of DNA from the infectious unit [6, 13] . The proposed 'unified theory' creates a marriage between two seemingly opposing views by suggesting infectivity is a function of PrP sc activity, whereas strain diversity is explained by recruited RNA molecules [19] . Other ideas include diversification due to post-translational modifications, or some other non-nucleic acid component [10] . Non-covalently bound cofactors that impose strain specificity could include peptides, oligosaccharides, fatty acids, sterols, or other compounds [10] . It is also conceivable that strain variation could be explained in part by conformers of the PrP protein [1] . It is likely that the conceptual difficulty of the existence of prion strains in a protein only model is a result of poor interactions between heterologous PrP proteins, as defined by amino acid sequence.
Replication of PrP and infectivity
The accumulation of PrP s~ proteins and infectivity in diseased animals is relatively slow [2] . Inhibition of accumulation is correlated with inhibition of infectivity and PrP s~ replication [10] . The replication of infectivity has been shown to be dependent upon PrP sc conversion [2, 17] . As previously discussed, the conversion of PrP c to PrP sc rests on post-translational changes in the protein which are not completely understood [2] . It is known, at least, that the interaction of PrP sc and PrP c is required for conversion [10] . The site of PrP sc synthesis and accumulation is strain dependent, and not fully known.
Contingent upon the proposed interaction between the two isoforms for pathogenic conversion of PrP is evidence for PrP heterozygotes being protected from disease. It has been demonstrated that humans heterozygous for codon 129 (Met/ Val) are protected from sporadic CJD [1] (see Table 2 ). Given that the interacting PrP s~ and 237 PrP c are homologous, disease will develop with a greater frequency [1] . Besides providing further evidence for a central role of PrP in disease pathology, these results indicate that PrP heterology, as defined by amino acid sequence, promotes poor interactions and a decreased likelihood of successful 'infection'.
Initial transmission is stochastic and inefficient, after which it becomes autocatalytic [10] . The conversion of PrP c to PrP sc by PrP s~ is proposed to be the mechanism of prion replication. This model has been elegantly described in a recent paper by . The conformational conversion to pathologic PrP is achieved as PrP sc imposes its conformation on PrP c, and converted molecules then act as templates for additional conformational impositions leading to the accumulation of PrP s~ [1] . This model derives considerable credence from many lines of evidence, including recent work displaying structural differences between the two isoforms of PrP [12] .
PrP in transgenic mouse models
Incontrovertible evidence for prion involvement in SE diseases has come from experiments involving transgenic animals. PrP °/° mice, in which the gene coding for PrP has been ablated, develop normally [14, 15] , arguing that PrP is not necessary in normal development. These animals do not develop disease when inoculated with scrapie agent [15, 23] . Not only do they not develop disease, but PrP sc is not detectable [15, 23] , in agreement that homologous protein is required for replication, and that PrP sc is the transmissible agent in the disease while playing a major role in the observed neuropathology. PrP +/° animals display delayed onset of symptoms, and a decreased titer of PrP sc [23] , demonstrating a correlation between titer and pathogenicity. Similarly designed experiments have provided further evidence for the link between PrP gene dosage and disease. Animals transgenic for multiple copies of wild type PrP were studied compared to heterozygous transgenic animals. Half of Tg (PrP+/+)7 animals developed disease within 460 days, whereas none of the Tg(PrP +/°)7 developed disease before 650 days [3] . Codon 101 mutations in mouse PrP (Pro to Leu; analogous to codon 102 mutations in human GSS) have also been tested transgenically. Mice with the mutant isoform spontaneously develop clinical symptoms and pathological lesions identical to mouse scrapie [24] .
Other experiments have been constructed to examine the interaction between host genetics and inoculum genetic origin. Mice transgenic for hamster PrP were found to be sensitive to transmission of disease by hamster PrP s~, when they would normally be resistant, and the disease could also be passed back into hamsters [21] . Mousehamster chimeric PrP in mice infected with hamster PrP resulted in the creation of a new strain of scrapie, which may allow for dissection of the species barrier [22] . These results provide further evidence for the need of interacting protein homology for successful transmission events, while also demonstrating the positive relationship between incubation time and gene expression [21, 22] .
Final comments
The enigma of prion diseases is beginning to become more fully understood. The unique feature of SE diseases that they are both genetic and infectious will likely have wider ranging biological implications once disease mechanisms are fully realized. Pathological mechanisms and transrnissibility are due to PrP so, a concept that was initially met with skepticism and reservation. Key issues are still to be resolved more completely. The primary point of interest is elucidating the exact mechanism of PrP sc replication and a description of PrP conformers involved in transmission, replication, and pathology. A problem remains in accurately diagnosing sporadic and/or infectious SE disease in animals. Although familial cases can be identified in humans decades before onset, what will constitute an effective and rational therapy? The normal function of PrP remains a mystery. However, understanding its function may provide clues to solving SE and other related neurodegenerative diseases.
